论文部分内容阅读
目的:探讨米非司酮联合中药汤剂保守治疗宫外孕的临床疗效,为宫外孕保守治疗提供临床参考依据。方法:将我院08年1月至13年1月收治的36名宫外孕患者平均分为两组,对照组和治疗组,每组18人。对照组患者对其采用西医治疗方案:给予患者米非司酮治疗。治疗组对其采用西医治疗方案的同时对患者同时采用中医汤剂治疗方案、米非司酮同时使用。采用统计学方法统计两组患者的疗效,包括治愈率和不良反应。总结两种方案的优缺点。结果:治疗组的治愈率为88.89%,对照组的治愈率为66.67%,治疗组和对照组的治愈率差异有统计学意义(p<0.05);治疗组的不良反应发生率为38.89%,对照组不良反应发生率为33.33%,治疗组和对照组的不良反应发生率差异无统计学意义(p>0.05)。结论:采用米非司酮联合中药汤剂保守治疗宫外孕的中西医结合方案比单独对患者使用米非司酮治疗方案的成功率高,疗效令人满意,不良反应相对减少,同时并没有大幅度提高临床治疗成分,值得广大医务工作者大力推广使用。
Objective: To investigate the clinical efficacy of mifepristone combined with traditional Chinese medicine decoction in the conservative treatment of ectopic pregnancy, and provide clinical reference for the conservative treatment of ectopic pregnancy. Methods: Thirty-six ectopic pregnancy patients admitted to our hospital from January 2008 to January 2013 were divided into two groups, control group and treatment group, with 18 in each group. Patients in the control group were treated with western medicine: Mifepristone was given to the patients. The treatment group adopted the western medicine treatment plan, meanwhile used the Chinese medicine decoction treatment plan to the patients at the same time, mifepristone was used at the same time. The efficacy of the two groups of patients was statistically analyzed, including the cure rate and adverse reactions. Summary of the advantages and disadvantages of the two programs. Results: The cure rate of the treatment group was 88.89%, the cure rate of the control group was 66.67%, the cure rate of the treatment group and the control group was statistically significant (p <0.05); the incidence of adverse reactions in the treatment group was 38.89% The incidence of adverse reactions in the control group was 33.33%, there was no significant difference in the incidence of adverse reactions between the treatment group and the control group (p> 0.05). Conclusion: The combination of traditional Chinese and western medicine with conservative treatment of ectopic pregnancy by mifepristone combined with traditional Chinese medicine decoction has a higher success rate than mifepristone treatment alone, with satisfactory curative effect and relatively fewer side effects. Meanwhile, there is no significant difference Improve clinical treatment components, it is worth the majority of medical workers to promote the use of.